162 related articles for article (PubMed ID: 27407277)
1. Macrophage activation syndrome in a patient with systemic onset of the juvenile idiopathic arthritis.
Jain D; Aggarwal HK; Rao A; Mittal A; Jain P
Reumatologia; 2016; 54(1):42-7. PubMed ID: 27407277
[TBL] [Abstract][Full Text] [Related]
2. A pruritic linear urticarial rash, fever, and systemic inflammatory disease in five adolescents: adult-onset still disease or systemic juvenile idiopathic arthritis sine arthritis?
Prendiville JS; Tucker LB; Cabral DA; Crawford RI
Pediatr Dermatol; 2004; 21(5):580-8. PubMed ID: 15461768
[TBL] [Abstract][Full Text] [Related]
3. Systemic onset juvenile idiopathic arthritis: a single center experience.
Sağ E; Uzunoğlu B; Bal F; Sönmez HE; Demir S; Bilginer Y; Özen S
Turk J Pediatr; 2019; 61(6):852-858. PubMed ID: 32134578
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.
Davidson N; Rangarajan HG; Driest K; Bajwa RPS; Polishchuk V; Abu-Arja RF
Case Rep Rheumatol; 2021; 2021():9323141. PubMed ID: 34123455
[TBL] [Abstract][Full Text] [Related]
5. Is it possible to predict a disease course prone to macrophage activation syndrome at systemic juvenile idiopathic arthritis diagnosis?
Batu ED; Sener S; Balık Z; Bayındır Y; Cam V; Kasap Cuceoglu M; Uysal O; Aliyev E; Basaran Ö; Bilginer Y; Özen S
Clin Rheumatol; 2024 Jan; 43(1):415-421. PubMed ID: 38012469
[TBL] [Abstract][Full Text] [Related]
6. Occult macrophage activation syndrome in systemic-onset juvenile idiopathic arthritic syndrome--a case report.
Zeng P; Li F; Zeng H
Acta Reumatol Port; 2013; 38(3):196-200. PubMed ID: 24149017
[TBL] [Abstract][Full Text] [Related]
7. Anakinra and hepatotoxicity in pediatric rheumatology: a case series.
Martins FR; Azevedo AC; Ganhão S; Aguiar F; Rodrigues M; Brito I
Pediatr Rheumatol Online J; 2023 Oct; 21(1):112. PubMed ID: 37803456
[TBL] [Abstract][Full Text] [Related]
8. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
[TBL] [Abstract][Full Text] [Related]
9. Case Report: Refractory macrophage activation syndrome requiring high-dose anakinra, emapalumab, and etoposide therapy in early-onset systemic juvenile idiopathic arthritis associated with adenoviremia.
Slaney ED; Modica R; Woolnough L; Kafisheh D; Bell-Brunson DH; Elder M
Front Pediatr; 2023; 11():1336554. PubMed ID: 38322244
[TBL] [Abstract][Full Text] [Related]
10. Systemic Juvenile Idiopathic Arthritis.
Lee JJY; Schneider R
Pediatr Clin North Am; 2018 Aug; 65(4):691-709. PubMed ID: 30031494
[TBL] [Abstract][Full Text] [Related]
11. Case report: Emapalumab for active disease control prior to hematopoietic stem cell transplantation in refractory systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.
Chellapandian D; Milojevic D
Front Pediatr; 2023; 11():1123104. PubMed ID: 36891226
[TBL] [Abstract][Full Text] [Related]
12. An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.
Arduini A; Marasco E; Marucci G; Pardeo M; Insalaco A; Caiello I; Moneta GM; Prencipe G; De Benedetti F; Bracaglia C
Pediatr Rheumatol Online J; 2019 May; 17(1):25. PubMed ID: 31118063
[TBL] [Abstract][Full Text] [Related]
13. Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis.
Yokota S; Tanaka T; Kishimoto T
Ther Adv Musculoskelet Dis; 2012 Dec; 4(6):387-97. PubMed ID: 23227116
[TBL] [Abstract][Full Text] [Related]
14. Tocilizumab in the treatment of systemic juvenile idiopathic arthritis.
Murakami M; Tomiita M; Nishimoto N
Open Access Rheumatol; 2012; 4():71-79. PubMed ID: 27790014
[TBL] [Abstract][Full Text] [Related]
15. Sudden Hypotension and Increased Serum Interferon-γ and Interleukin-10 Predict Early Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis.
Guo L; Xu Y; Qian X; Zou L; Zheng R; Teng L; Zheng Q; Leung Jung LK; Lu M
J Pediatr; 2021 Aug; 235():203-211.e3. PubMed ID: 33581106
[TBL] [Abstract][Full Text] [Related]
16. A rare case of coronary artery complication in a child with systemic juvenile idiopathic arthritis and macrophage activation syndrome: case report and literature review.
Zhang L; Wei Y; Zeng N; Wang L; Chen X; Yang J; Xiao X
Pediatr Rheumatol Online J; 2024 Jan; 22(1):4. PubMed ID: 38166957
[TBL] [Abstract][Full Text] [Related]
17. Macrophage activation syndrome in an inadequately treated patient with systemic onset juvenile idiopathic arthritis.
Juneja M; Jain R; Mishra D
Kathmandu Univ Med J (KUMJ); 2009; 7(28):411-3. PubMed ID: 20502084
[TBL] [Abstract][Full Text] [Related]
18. [Macrophage activation syndrome associated with systemic juvenile idiopathic arthritis].
Silva CA; Silva CH; Robazzi TC; Lotito AP; Mendroni Junior A; Jacob CM; Kiss MH
J Pediatr (Rio J); 2004; 80(6):517-22. PubMed ID: 15622430
[TBL] [Abstract][Full Text] [Related]
19. Patient characteristics associated with response to NSAID monotherapy in children with systemic juvenile idiopathic arthritis.
Sura A; Failing C; Sturza J; Stannard J; Riebschleger M
Pediatr Rheumatol Online J; 2018 Jan; 16(1):2. PubMed ID: 29304824
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]